The HIFI Study shows HIFU offers comparable efficacy and improved functional outcomes versus radical prostatectomy for localized prostate cancer.Quiver AI SummaryEDAP TMS SA announced the publication of...
EDAP TMS reports successful ex vivo histotripsy lesion generation using Focal One® technology, promoting innovation in non-invasive therapies.Quiver AI SummaryEDAP TMS SA has announced a successful presentation...
Robotic HIFU treatment for rectal endometriosis shows fewer complications and shorter hospital stays compared to traditional surgery.Quiver AI SummaryEDAP TMS SA announced positive clinical results regarding...
Rockwell Medical RMTI is scheduled to report third-quarter 2024 results on Nov. 11, before the opening bell.In the last reported quarter, the company’s adjusted earnings of 1 cent exceeded the Zacks...
Good times continue for Rockwell Medical RMTI stock. Back-to-back big announcements over the recent months, like the company’s new launches for home hemodialysis, a multi-million-dollar distribution...
EDAP TMS EDAP has taken a significant step toward expanding its AI-assisted prostate cancer care through a strategic collaboration with AI healthcare company Avenda Health. This partnership is centered...
Rockwell Medical RMTI delivered an impressive performance through 2024, with its stock witnessing more than 108% year-to-date surge, outperforming the 15.5% rise of the industry and the benchmark’s 18.1%...
Company to host conference call and webcast on Thursday, August 25th at 8:30 am EDT LYON, France, August 3, 2022 - EDAP TMS SA (Nasdaq: EDAP), the...
Proposed rule, if adopted for CY23, would increase Medicare Payment for a Focal One HIFU procedure completed on an outpatient basis at a hospital LYON,...
LYON, France, June 28, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced its...